Back

Middle-aged mice treated with GHK-Cu peptide administered intraperitoneally or intranasally show behavioral rescue but divergent hippocampal aging programs

Mazzola, J. M.; Rosenfeld, M.; Tucker, M.; Wezeman, J.; Ladiges, W. C.; Liao, G. Y.

2026-04-13 pharmacology and toxicology
10.64898/2026.04.09.717524 bioRxiv
Show abstract

Age-related cognitive decline (ARCD) is driven by conserved biological mechanisms of aging, yet no gerotherapeutic directly targets these processes in the brain. Glycyl-L-histidyl-L-lysine complexed with copper (GHK-Cu) is an endogenous peptide with regenerative and anti-inflammatory properties that declines with age. Whether its effects on cognitive aging depend on delivery route or exposure duration remains unclear. Aged C57BL/6J mice (20-21 months) received GHK-Cu (15 mg/kg) via short-term intraperitoneal (IP; 5 days) or longer-term intranasal (IN; 8 weeks) administration. Hippocampal-dependent escape learning was assessed using a spatial navigation task. Molecular effects were evaluated using hippocampal immunohistochemistry and bulk RNA sequencing. Differential gene expression was analyzed using DESeq2 with false discovery rate (FDR) correction, and pathway-level changes were assessed via gene set enrichment analysis (GSEA). IN GHK-Cu improved escape latency across Trials 2-4 in both sexes (P < 0.05), whereas IP dosing produced a transient improvement in males during Trial 2 (P < 0.05) without sustained effects or improvement in females. IN treatment increased synaptophysin in females (P < 0.001) and decreased GFAP in both sexes (P < 0.01), while IP treatment reduced TGF-{beta}, GFAP, and MCP-1 in males (P < 0.05) and decreased p21 in females (P < 0.0001). Transcriptomic analysis revealed distinct molecular programs. IN GHK-Cu induced coordinated suppression of oxidative phosphorylation (male NES -5.44, female NES -4.20; FDR < 0.0001) and MYC target pathways (female NES -4.31, FDR < 0.0001), with additional attenuation of PI3K-AKT-mTOR signaling in females (NES -3.15, FDR = 0.062). In contrast, IP treatment activated oxidative phosphorylation (female NES 4.97, FDR < 0.001), DNA repair (NES 5.58, FDR < 0.001), and MYC targets (NES 4.34, FDR = 0.002), indicating engagement of acute stress-response and repair pathways. GHK-Cu improves hippocampal-dependent learning in aged mice through distinct biological modes: IP exposure activates repair and stress-response pathways, whereas IN delivery induces sustained suppression of growth and mitochondrial metabolic signaling associated with aging biology. These findings demonstrate that functional cognitive improvement can arise from divergent molecular states and identify administrative route and exposure duration as key determinants of gerotherapeutic response.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Aging Cell
144 papers in training set
Top 0.3%
22.5%
2
The Journals of Gerontology: Series A
25 papers in training set
Top 0.1%
17.5%
3
npj Aging
15 papers in training set
Top 0.1%
14.3%
50% of probability mass above
4
The Journal of Prevention of Alzheimer's Disease
10 papers in training set
Top 0.1%
4.8%
5
Alzheimer's Research & Therapy
52 papers in training set
Top 0.5%
4.2%
6
Scientific Reports
3102 papers in training set
Top 37%
3.6%
7
eLife
5422 papers in training set
Top 32%
2.6%
8
Nature Communications
4913 papers in training set
Top 51%
1.7%
9
GeroScience
97 papers in training set
Top 1.0%
1.7%
10
Neurobiology of Disease
134 papers in training set
Top 3%
1.7%
11
Neurobiology of Aging
95 papers in training set
Top 1%
1.5%
12
Biomedicine & Pharmacotherapy
43 papers in training set
Top 0.6%
1.2%
13
Aging
69 papers in training set
Top 3%
0.8%
14
Neuropsychopharmacology
134 papers in training set
Top 2%
0.8%
15
Archives of Toxicology
14 papers in training set
Top 0.3%
0.7%
16
Advanced Science
249 papers in training set
Top 19%
0.7%
17
JCI Insight
241 papers in training set
Top 7%
0.7%
18
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 1%
0.7%
19
The Journal of Pharmacology and Experimental Therapeutics
15 papers in training set
Top 0.5%
0.7%
20
PLOS ONE
4510 papers in training set
Top 69%
0.7%
21
Nucleic Acids Research
1128 papers in training set
Top 19%
0.7%
22
Frontiers in Aging Neuroscience
67 papers in training set
Top 4%
0.6%
23
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
22 papers in training set
Top 0.4%
0.6%